Valbiotis Announces the Completion of Recruitment for the Phase II HEART Clinical Study Conducted With TOTUM •070 in Hypercholesterolemia

LA ROCHELLE, France. Sept 6, 2021 - Valbiotis, a French research and development company committed to scientific innovation for preventing and combating metabolic diseases, announces that it has completed the recruitment of 120 volunteers for the...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials